Brimonidine

Common brands: Brimonidine, Alphagan P, Xalatan, Xelpros, Latanoprost

Top reporter: Sandoz Inc

Prostaglandin Analog [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Corticosteroid [EPC]Carbonic Anhydrase Inhibitor [EPC]Platelet Aggregation Inhibitor [EPC]
17,334
Total Reports
4,735
Serious Reports
737
Death Reports
30
Reported Reactions
Death Report Ratio: Moderate (4.25%)

Patient Demographics

Male
6,571
Female
9,754

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Brimonidine.

# Reaction Reports % of Total
1 TREATMENT FAILURE 2,868
16.3%
2 DRUG INEFFECTIVE 1,261
7.1%
3 ERYTHEMA 746
4.2%
4 EYE IRRITATION 742
4.2%
5 OCULAR HYPERAEMIA 737
4.2%
6 EYE PAIN 717
4.1%
7 HYPERSENSITIVITY 695
3.9%
8 FATIGUE 688
3.9%
9 OFF LABEL USE 676
3.8%
10 INTRAOCULAR PRESSURE INCREASED 609
3.5%
11 VISION BLURRED 608
3.4%
12 DIZZINESS 538
3.1%
13 HEADACHE 531
3.0%
14 CONDITION AGGRAVATED 482
2.7%
15 DIARRHOEA 456
2.6%
16 DYSPNOEA 422
2.4%
17 DEATH 407
2.3%
18 NAUSEA 404
2.3%
19 FALL 392
2.2%
20 VISUAL IMPAIRMENT 386
2.2%
21 GLAUCOMA 366
2.1%
22 ASTHENIA 362
2.1%
23 PAIN 341
1.9%
24 PRURITUS 336
1.9%
25 EYE PRURITUS 328
1.9%
26 DRUG HYPERSENSITIVITY 325
1.8%
27 RASH 318
1.8%
28 FLUSHING 305
1.7%
29 PRODUCT DOSE OMISSION ISSUE 304
1.7%
30 DRY EYE 289
1.6%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.